Multiple Myeloma

ASCO: Teclistamab Improves Survival in Relapsed, Refractory Multiple Myeloma

Physician’s Briefing

ASCO: Teclistamab Improves Survival in Relapsed, Refractory Multiple Myeloma

02 Jun 2026

2 min read

Multiple Myeloma Linked to Higher Risk for Hematologic Second Cancers

Physician’s Briefing

Multiple Myeloma Linked to Higher Risk for Hematologic Second Cancers

30 Apr 2026

1 min read

A-Fib Occurs Frequently in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Physician’s Briefing

A-Fib Occurs Frequently in Patients With Multiple Myeloma Undergoing Stem Cell Transplant

26 Feb 2026

1 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com